Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Mass General Brigham Ventures is a corporate venture capital organization established in 2008, affiliated with the Mass General Brigham healthcare system in Massachusetts. The firm focuses on supporting innovation in the healthcare sector through strategic investments in early to growth-stage companies. It leverages its connection to one of the largest hospital system-based research enterprises in the U.S. to access disruptive deal flow and invest in technologies that enhance patient care.
As of now, Mass General Brigham Ventures has invested in over 55 companies, achieving more than 20 successful exits, including 8 IPOs and 12 mergers and acquisitions. The firm operates with a fund size of $30 million, which includes a dedicated $30 million AI and Digital Innovation Fund established in 2020. This dual fund structure allows the organization to target both traditional life sciences and emerging digital health technologies.
Headquartered in Massachusetts, Mass General Brigham Ventures is part of a leading healthcare system that includes prestigious institutions such as Massachusetts General Hospital and Brigham and Women's Hospital. The firm’s notable milestones include its extensive portfolio and its reputation for providing top venture returns.
Mass General Brigham Ventures invests primarily in healthcare-related companies, with a focus on drugs, devices, diagnostics, and digital health. The firm targets early to growth-stage investments, specifically in pre-seed, seed, seed-plus, Series A, Series B, and growth equity stages. While the organization primarily focuses on U.S.-based companies, it remains open to international opportunities that align with its mission to improve healthcare delivery and patient outcomes.
The investment thesis emphasizes technologies and services that can significantly enhance patient care. Mass General Brigham Ventures seeks to identify and support next-generation life science companies based on intellectual property from the Mass General Brigham research community. The firm also values strong co-investor syndicates to enhance the support and resources available to its portfolio companies.
Mass General Brigham Ventures has built a diverse portfolio of over 55 companies since its inception. The firm has achieved more than 20 successful exits, including 8 IPOs and 12 mergers and acquisitions. While specific portfolio companies were not detailed in the available information, the organization maintains a portfolio page on its website, which provides insights into its investments.
Notable exits include companies that have successfully gone public or been acquired, showcasing the firm’s ability to identify and nurture high-potential startups in the healthcare sector. The firm’s portfolio reflects its commitment to investing in technologies that improve patient care and healthcare delivery.
To pitch to Mass General Brigham Ventures, startups should submit their proposals through the firm’s website at massgeneralbrighamventures.com. It is recommended to include a comprehensive pitch deck that outlines the technology, market potential, team qualifications, and financial projections. The firm appreciates clear and concise presentations that effectively communicate the startup's value proposition.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions can enhance the chances of a successful pitch, so leveraging connections within the healthcare or venture capital community can be beneficial.
What are the investment criteria for Mass General Brigham Ventures?
The firm focuses on healthcare-related companies, particularly in drugs, devices, diagnostics, and digital health. It invests in early to growth-stage companies, primarily in the U.S., but is open to international opportunities that align with its mission.
How can startups apply or pitch to Mass General Brigham Ventures?
Startups can submit their pitch through the firm’s website at massgeneralbrighamventures.com. It is advisable to include detailed information about the technology, market potential, and team in the pitch deck.
What makes Mass General Brigham Ventures different from other investors?
The firm is affiliated with one of the largest hospital system-based research enterprises in the U.S., providing privileged access to intellectual property and research. This unique position allows them to identify and invest in disruptive innovations early.
What is the geographic scope of Mass General Brigham Ventures?
While the firm primarily invests in U.S.-based healthcare companies, it is open to considering opportunities in other geographies that align with its mission to enhance patient care.
What is the fund size and check size range for investments?
Mass General Brigham Ventures operates with a fund size of $30 million, with investments typically made in early to growth-stage companies. Check sizes vary based on the stage and specific needs of the startup.
What kind of post-investment involvement does Mass General Brigham Ventures have?
The firm provides its portfolio companies with access to its extensive research network and resources, which can include operational support and strategic guidance to enhance growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.